Profile data is unavailable for this security.
About the company
Worldwide Healthcare Trust PLC is a specialist investment trust. It invests in the global healthcare sector with the objective of achieving a high level of capital growth. It invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It will not invest more than 15% of the portfolio in any one individual stock at the time of acquisition. It invests over 50% of the portfolio in larger companies, and 20% of the portfolio in smaller companies. It may invest 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. It may invest 40% of the portfolio in companies in the healthcare equipment and supplies sector and 30% of the portfolio in companies in the healthcare providers and services sector. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.
- Revenue in GBP (TTM)-148.71m
- Net income in GBP-168.47m
- Incorporated1995
- Employees0.00
- LocationWorldwide HealthcareFrostrow Capital LLP25 Southampton BuildingsLONDON WC2A 1ALUnited KingdomGBR
- Phone+44 20 3008 4910
- Websitehttps://www.worldwidewh.com/
Profile
| Management group(s) | Frostrow Capital LLP |
|---|---|
| AIC sector | Biotechnology & Healthcare |
| ISIN | GB00BN455J50 |
| Launch date | 28 Apr 1995 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | GBP |
Objective
In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.
Managed by
| Sven H. Borho, Trevor M. Polischuk |
|---|
Management & contract fees
The Investment Manager receives a fee equal to 0.65% p.a. of the NAV of Company. The performance fee amounts to 15% of any outperformance of the NAV over the benchmark index. The Company may be terminated by either party giving notice of not less than 12 months.
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Temple Bar Investment Trust PLC | 174.18m | 164.02m |
| Sequoia Economic Infrastrctr Incm Fd Ltd | 97.77m | 79.56m |
| Herald Investment Trust plc | 46.46m | 31.67m |
| JPMorgan Japanese Investment Trust PLC | 249.86m | 241.40m |
| Schiehallion Fund Ltd | 250.71m | 241.08m |
| Bankers Investment Trust PLC | 230.72m | 216.69m |
| Aberforth Smaller Companies Trust plc | 114.11m | 96.24m |
| Worldwide Healthcare Trust PLC | -148.71m | -168.47m |
| Rosebank Industries PLC | -100.00bn | -100.00bn |
| JPMorgan Emerging Mkts Grt & Inc PLC | 65.23m | 49.48m |
| BH Macro Ltd | 329.57m | 198.31m |
| Burford Capital Limited | 347.55m | 64.00m |
| Fidelity Special Values PLC | 172.69m | 158.39m |
| Fidelity China Special Situations PLC | 590.06m | 557.14m |
| Law Debenture Corporation plc | 252.53m | 169.96m |
| Smithson Investment Trust PLC | 106.55m | 83.49m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Rathbones Investment Management Ltd.as of 29 Jul 2025 | 66.14m | 17.03% |
| TrinityBridge Ltd.as of 01 Jan 2026 | 11.90m | 3.07% |
| Quilter Cheviot Ltd.as of 01 Jan 2026 | 7.22m | 1.86% |
| Hargreaves Lansdown Fund Managers Ltd.as of 01 Jan 2026 | 7.20m | 1.85% |
| J. M. Finn & Co. Ltd.as of 01 Jan 2026 | 5.90m | 1.52% |
| Vanguard Asset Management Ltd.as of 31 Dec 2025 | 5.58m | 1.44% |
| Saba Capital Management LPas of 12 Jun 2025 | 4.02m | 1.04% |
| HSBC Global Asset Management (UK) Ltd.as of 01 Jan 2026 | 3.36m | 0.87% |
| The Vanguard Group, Inc.as of 01 Jan 2026 | 2.89m | 0.74% |
| BlackRock Investment Management (UK) Ltd.as of 01 Jan 2026 | 2.55m | 0.66% |
